HCMSG - Hepatitis C Mentor & Support Group, Inc.

  • Home
  • OUR SERVICES
    • RESOURCES
    • The Circle Model >
      • Circle Model Data Form
    • Hep C Training English
    • Hep C Training Spanish
    • Order Materials
    • Group and Facilitator Guide
    • Webinars
  • About Us
    • Our Mission
    • Board of Directors
    • Support Us
    • Medical Advisors
    • Contact Us
  • Blog
  • Home
  • OUR SERVICES
    • RESOURCES
    • The Circle Model >
      • Circle Model Data Form
    • Hep C Training English
    • Hep C Training Spanish
    • Order Materials
    • Group and Facilitator Guide
    • Webinars
  • About Us
    • Our Mission
    • Board of Directors
    • Support Us
    • Medical Advisors
    • Contact Us
  • Blog

This weight-loss hormone may protect the liver even without weight loss

8/25/2026

0 Comments

 
Published August 21, 2026 Originally published on ScienceDaily Top Science MD Linx
​Researchers at McMaster University have uncovered an unexpected role for a naturally occurring hormone already known for reducing appetite and supporting weight loss. The hormone appears to protect the liver from inflammation through a previously unknown signaling pathway, a finding that could point toward new approaches for treating advanced fatty liver disease.
The study, published in Cell Metabolism on August 10, 2026, found that GDF15 can reduce liver inflammation and slow the development of liver scarring even when weight loss does not occur. The result challenges the long-held view that the hormone's benefits are primarily tied to its effects on appetite and body weight.

A New Target for Advanced Fatty Liver Disease

Millions of people around the world are affected by metabolic dysfunction-associated steatohepatitis (MASH), an advanced form of fatty liver disease that can eventually lead to cirrhosis, liver cancer, and liver failure. New weight loss medications have helped improve outcomes for many patients, but inflammation in the liver can remain even after substantial weight loss.

By identifying a biological pathway that directly regulates this inflammation, the new findings suggest that future therapies could potentially target liver inflammation alongside existing treatments focused on weight and liver fat.

"Our findings show that GDF15 does much more than regulate appetite and body weight," says Gregory Steinberg, professor in McMaster University's Department of Medicine, co-director of the Centre for Metabolism, Obesity and Diabetes Research (MODR), and senior author of the study. "We discovered that GDF15 activates a natural brain-to-liver signaling pathway that helps suppress liver inflammation and reduce fibrosis. This changes how we think about the hormone and suggests it may be part of the body's own defense system against chronic liver injury."
Researchers at McMaster University have uncovered an unexpected role for a naturally occurring hormone already known for reducing appetite and supporting weight loss. The hormone appears to protect the liver from inflammation through a previously unknown signaling pathway, a finding that could point toward new approaches for treating advanced fatty liver disease.
The study, published in Cell Metabolism on August 10, 2026, found that GDF15 can reduce liver inflammation and slow the development of liver scarring even when weight loss does not occur. The result challenges the long-held view that the hormone's benefits are primarily tied to its effects on appetite and body weight.

A New Target for Advanced Fatty Liver Disease

Millions of people around the world are affected by metabolic dysfunction-associated steatohepatitis (MASH), an advanced form of fatty liver disease that can eventually lead to cirrhosis, liver cancer, and liver failure. New weight loss medications have helped improve outcomes for many patients, but inflammation in the liver can remain even after substantial weight loss.

By identifying a biological pathway that directly regulates this inflammation, the new findings suggest that future therapies could potentially target liver inflammation alongside existing treatments focused on weight and liver fat.

"Our findings show that GDF15 does much more than regulate appetite and body weight," says Gregory Steinberg, professor in McMaster University's Department of Medicine, co-director of the Centre for Metabolism, Obesity and Diabetes Research (MODR), and senior author of the study. "We discovered that GDF15 activates a natural brain-to-liver signaling pathway that helps suppress liver inflammation and reduce fibrosis. This changes how we think about the hormone and suggests it may be part of the body's own defense system against chronic liver injury."

TO CONTINUE READING:  ​https://www.mdlinx.com/news/this-weight-loss-hormone-may-protect-the-liver-even-without-weight-loss/30Q3RUmIVLLcHyL6ioMQfh?show_order=6&utm_campaign=reg_daily-alert_20260825_daily-nl-am-v4_registered-users-a180_other&utm_source=iterable&utm_medium=email&utm_content=MorningDaily
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Archives

    September 2026
    August 2026
    May 2026
    April 2026
    March 2026
    February 2026
    January 2026
    December 2025
    November 2025
    October 2025
    August 2025
    July 2025
    June 2025
    April 2025
    March 2025
    January 2025
    December 2024
    September 2024
    August 2024
    July 2024
    June 2024
    May 2024
    April 2024
    March 2024
    February 2024
    December 2023
    November 2023
    October 2023
    September 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021

    Categories

    All

    RSS Feed

Privacy Policy
Disclaimer:  Information given by Hepatitis C Mentor and Support Group is not a substitute for advice given by your physician or health care provider.  We do not endorse any doctor, hospital, medical group, or treatment.